Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Yancopoulos (2010)
Clinical Application of Therapies Targeting VEGFCell, 143
A. Kirmizis, S. Bartley, P. Farnham (2003)
Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy.Molecular cancer therapeutics, 2 1
J. Kim, Jin Kim, Chang Cho, H. Jun, Dong Kim, Y. Yu, Kyu-Won Kim (2010)
Differential roles of matrix metalloproteinase-9 and -2, depending on proliferation or differentiation of retinoblastoma cells.Investigative ophthalmology & visual science, 51 3
M. Duffy, PM McGowan, W. Gallagher (2008)
Cancer invasion and metastasis: changing viewsThe Journal of Pathology, 214
Diego Pasini, A. Bracken, M. Jensen, E. Denchi, K. Helin (2004)
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activityThe EMBO Journal, 23
Jindan Yu, Jianjun Yu, D. Rhodes, S. Tomlins, Xuhong Cao, Guoan Chen, R. Mehra, Xiaoju Wang, D. Ghosh, R. Shah, S. Varambally, K. Pienta, A. Chinnaiyan (2007)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.Cancer research, 67 22
M. Hahn, T. Hahn, Dong-Hyun Lee, R. Esworthy, Byung-Wook Kim, A. Riggs, F. Chu, G. Pfeifer (2008)
Methylation of polycomb target genes in intestinal cancer is mediated by inflammation.Cancer research, 68 24
D. Iliopoulos, Marianne Lindahl-Allen, C. Polytarchou, H. Hirsch, P. Tsichlis, K. Struhl (2010)
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.Molecular cell, 39 5
P. Temming, A. Eggert, N. Bornfeld, W. Sauerwein, S. Göricke, D. Lohmann (2013)
Diagnose und Behandlung des Retinoblastoms: aktuelle Konzepte zur sicheren Tumorkontrolle bei Erhalt des SehvermögensKlin Monatsbl Augenheilkd, 230
Temming (2013)
Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of visionKlin Monbl Augenheilkd, 230
A. Kirmizis, S. Bartley, A. Kuzmichev, R. Margueron, D. Reinberg, Roland Green, P. Farnham (2004)
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.Genes & development, 18 13
Hua Long, Bo Zhou, Fa-gang Jiang (2011)
Expression of MMP-2 and MMP-9 in retinoblastoma and their significance.International journal of ophthalmology, 4 5
Diego Pasini, A. Bracken, J. Hansen, M. Capillo, K. Helin (2007)
The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell DifferentiationMolecular and Cellular Biology, 27
S. Freedland, E. Humphreys, L. Mangold, M. Eisenberger, F. Dorey, P. Walsh, A. Partin (2005)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.JAMA, 294 4
J. Marshall (2011)
Transwell(®) invasion assays.Methods in molecular biology, 769
A. Reis, F. Vargas, B. Lemos (2012)
More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastomaFrontiers in Genetics, 3
C. Kleer, Q. Cao, S. Varambally, R. Shen, I. Ota, S. Tomlins, D. Ghosh, R. Sewalt, A. Otte, D. Hayes, M. Sabel, D. Livant, S. Weiss, M. Rubin, A. Chinnaiyan (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 100
F. Crea, E. Hurt, W. Farrar (2010)
Clinical significance of Polycomb gene expression in brain tumorsMolecular Cancer, 9
Suppressor of Zeste 12 homolog (SUZ12) is known to regulate tumor phenotype through altering gene expression, with an important regulatory role in tumor genesis and development. SUZ12 has been widely investigated; however, no studies regarding the role of the SUZ12 gene in retinoblastoma (RB) have been conducted. In this study, SUZ12 small interfering (si)RNA was transfected into SO‑RB50 human RB cells. The influence of SUZ siRNA on RB cell invasion was detected using a soft agar colony forming assay and a Transwell cabin model. The effect of the SUZ12 siRNA on the expression levels of the associated proteins, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)‑9 and MMP‑2, was detected by western blotting. The number of cell clones was found to be reduced by the siRNA in a dose‑dependent manner, and the number of cells that had permeated through the filter membrane was reduced following transfection with the siRNA. SUZ12 inhibition resulted in a marked reduction in VEGF, MMP‑2 and MMP‑9 expression levels (0.26±0.04, 0.16±0.02 and 0.12±0.02, respectively) compared with the levels in the non‑transfected group (0.80±0.10, 0.94±0.16 and 1.15±0.18, respectively) (P<0.01). In conclusion, SUZ12 siRNA inhibited cell invasion and the expression of VEGF, MMP‑2 and MMP‑9 in SO‑RB50 retinoblastoma cells.
Oncology Letters – Spandidos Publications
Published: Nov 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.